Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
JAZZ
JAZZ
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
JAZZ News
PHARMA MAR - ROCHE AND JAZZ PHARMACEUTICALS COLLABORATE ON PHASE 3 IMFORTE TRIAL
3d ago
moomoo
American Nutrition Association Partners with Jazz Pharmaceuticals to Promote Low Sodium Diets
6d ago
Newsfilter
American Nutrition Association Partners with Jazz Pharmaceuticals to Promote Low Sodium Diets
6d ago
PRnewswire
Jazz Pharmaceuticals Unveils New Research Insights at AACR Annual Meeting
Mar 18 2026
PRnewswire
Investors Shift Focus to Updated Quant Ratings Post Earnings
Mar 14 2026
seekingalpha
S&P 500 Futures Decline in Pre-Market Trading; Jazz Pharmaceuticals and Live Nation Entertainment at the Forefront
Mar 09 2026
Barron's
Analysis of Growth Drivers in the Biliary Tract Cancer Market
Mar 02 2026
Newsfilter
Zymeworks Secures $250 Million Royalty-Backed Financing
Mar 02 2026
Yahoo Finance
Wall Street Analysts Adjust Ratings
Feb 27 2026
Benzinga
Key Wall Street Calls on Friday: Upgrades and Downgrades
Feb 27 2026
CNBC
MasTec and Jazz Pharmaceuticals See Active Options Trading
Feb 25 2026
NASDAQ.COM
Jazz Pharmaceuticals Reports Record Q4 2025 Earnings and Strategic Focus on Rare Diseases
Feb 25 2026
seekingalpha
Jazz Pharmaceuticals to Participate in Investor Conferences
Feb 17 2026
PRnewswire
Jazz Pharmaceuticals to Report Q4 and Full Year 2025 Results
Feb 10 2026
PRnewswire
Harmony Biosciences: Financial Success Amidst Challenges
Jan 27 2026
Fool
Harmony's Wakix Drug: Financial Success Amid Controversy
Jan 27 2026
NASDAQ.COM
Show More News
